Home Newsfeeds Oddo Securities Downgrades UBS Gr to Underperform

Oddo Securities Downgrades UBS Gr to Underperform

Oddo Securities analyst Roland Pfaender downgrades UBS Gr (NYSE:UBS) from Neutral to Underperform.

byBenzinga Newsdesk

March 20, 2023

1 minute read

Oddo Securities analyst Roland Pfaender downgrades UBS Gr (NYSE:UBS) from Neutral to Underperform.

News

FedRAMP Approves Additional Oracle Cloud Infrastructure Services

By Happy Mohamed

May 16, 8:13 AM

FedRAMP approves new OCI cloud services, now available to U.S. government agencies AUSTIN, Texas, May 16, 2023 /PRNewswire/ -- An expanded list of Oracle Cloud Infrastructure (OCI) services has

ORCL

Natuzzi Q4 2022, FY Earnings Release Scheduled For April 5, Due To Certain Additional Procedures Needed For Its China JV

By Charles Gross

April 5, 5:09 AM

Natuzzi S.p.A. (NYSE: NTZ) announced today that the Company is postponing its release of the Company's 2022 fourth quarter and full-year financial results and conference call, originally scheduled for April 5, 2023 and April 6, 2023, respectively.

NTZ

‘Tropical Trump’ Bolsonaro Trails Leftist Rival Lula In Brazil’s Presidential Polls

By Shivdeep Dhaliwal

October 3, 2:10 AM

Jair Bolsonaro, Brazil’s leader endorsed by former U.S. President Donald Trump, is trailing his left-wing rival Luiz Inácio Lula da Silva in the South American country’s presidential elections.

DWAC

Erasca Announces Publication Of Promising Clinical Data Supporting The Therapeutic Potential Of Naporafenib In Combination With Trametinib In NRAS-Mutant Melanoma

By Happy Mohamed

April 25, 8:08 AM

Promising preliminary antitumor activity with the combination demonstrated in heavily pretreated patients 47% ORR, 5.5 months mPFS observed with preferred combination dose of naporafenib 200 mg BID plus

ERAS

Oddo Securities Downgrades UBS Gr to Underperform

Related Posts

FedRAMP Approves Additional Oracle Cloud Infrastructure Services

Natuzzi Q4 2022, FY Earnings Release Scheduled For April 5, Due To Certain Additional Procedures Needed For Its China JV

‘Tropical Trump’ Bolsonaro Trails Leftist Rival Lula In Brazil’s Presidential Polls

Erasca Announces Publication Of Promising Clinical Data Supporting The Therapeutic Potential Of Naporafenib In Combination With Trametinib In NRAS-Mutant Melanoma